Released in The Lancet Oncology.

Cancer survival rates even now vary widely between Europe Cancer survival even now varies widely between Europe despite major improvements in cancer diagnosis and treatment during the first 10 years of the 21st century, based on the latest EUROCARE-5 reports covering over 50 percent of the adult and 77 percent of the childhood population of European countries. The findings, released in The Lancet Oncology, analysed data from malignancy registries covering all or part of 29 countries to compare 5-yr survival from analysis for a lot more than 9 million adults and 60 415 kids diagnosed between 2000 and 2007 ADHD symptoms .